Outset Medical, INC Schedule 13G passive stakes

Bank of America Corporation has disclosed a beneficial ownership of 666,596 shares, representing 3.5% of the outstanding common stock of Outset Medical, Inc.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 5.39% of Outset Medical, Inc.'s common stock as of June 30, 2026.

BML Investment Partners, L.P. has filed a Schedule 13G, reporting beneficial ownership of 13.6% of Outset Medical, Inc.'s common stock as of May 15, 2026.

Woodline Partners LP has disclosed a beneficial ownership of 1.6% in Outset Medical, Inc., holding 292,437 shares as of March 31, 2026.

BML Investment Partners, L.P. has filed a Schedule 13G, reporting beneficial ownership of 2,196,701 shares, representing 11.8% of Outset Medical, Inc.'s common stock.

The Vanguard Group reports zero beneficial ownership in Outset Medical Inc. following an internal reporting realignment.

BML Investment Partners, L.P. has reported a 10.5% beneficial ownership stake in Outset Medical, Inc., holding 1,902,201 shares of common stock.

Bank of America Corporation has reported a 5.2% beneficial ownership stake in Outset Medical, Inc., holding 950,558 shares of common stock.

BML Investment Partners, L.P. has reported a 9.4% beneficial ownership stake in Outset Medical, Inc., holding 1,705,876 shares of common stock.

Durable Capital Partners LP has reported a 7.6% beneficial ownership stake in Outset Medical, Inc., holding 1,366,823 shares of common stock.

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G, reporting beneficial ownership of 2,399 shares, representing 0.0% of Outset Medical Inc.'s common stock.

BlackRock, Inc. reported an increased beneficial ownership of 6.8% in Outset Medical, Inc.'s common stock, totaling 1,213,547 shares.

The Vanguard Group has reported a 5.59% beneficial ownership stake in Outset Medical Inc., holding 991,429 shares of common stock as of June 30, 2025.

BlackRock, Inc. has reported a 5.5% beneficial ownership stake in Outset Medical, Inc. common stock as of June 30, 2025.

Perceptive Advisors LLC and its affiliates, including Joseph Edelman, have filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in Outset Medical, Inc., comprising 1,208,334 shares.

Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a 9.61% beneficial ownership stake in Outset Medical, Inc., totaling 1,703,083 shares of common stock.

Woodline Partners LP, an investment adviser, has disclosed a passive beneficial ownership of 7.5% of Outset Medical, Inc.'s common stock.

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 8.9% in Outset Medical Inc., holding 1,603,056 shares of common stock.

FMR LLC and its affiliates, along with Abigail P. Johnson, have disclosed a combined beneficial ownership of 14.5% in Outset Medical Inc., as detailed in their latest Schedule 13G filing.

PFM Health Sciences, LP and its affiliated entities have disclosed a significant beneficial ownership stake of 9.4% in medical technology company Outset Medical, Inc.

Perceptive Advisors LLC, Joseph Edelman, and affiliated entities have disclosed a 9.5% beneficial ownership stake in Outset Medical, Inc., primarily through warrants.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a combined beneficial ownership of 7.0% in Outset Medical Inc. as of December 31, 2024.

The Vanguard Group has filed an amended Schedule 13G, indicating its beneficial ownership in Outset Medical Inc. has decreased to 4.96% as of December 31, 2024.

Durable Capital Partners LP has filed a Schedule 13G, revealing a significant 9.9% beneficial ownership stake in medical technology company Outset Medical, Inc.